Literature DB >> 28548312

Vitamin D-Dependent Rickets Type 1B (25-Hydroxylase Deficiency): A Rare Condition or a Misdiagnosed Condition?

Arnaud Molin1,2,3,4, Arnaud Wiedemann5,6, Nick Demers7, Martin Kaufmann7, Jérémy Do Cao5,6, Laurent Mainard6,8, Brigitte Dousset9, Pierre Journeau6,10, Geneviève Abeguile1, Nadia Coudray1, Hervé Mittre1,2,4, Nicolas Richard1,3, Georges Weryha6,11, Arthur Sorlin12, Glenville Jones7, Marie-Laure Kottler1,2,3, Francois Feillet5,6,13.   

Abstract

Vitamin D requires a two-step activation by hydroxylation: The first step is catalyzed by hepatic 25-hydroxylase (CYP2R1, 11p15.2) and the second one is catalyzed by renal 1α-hydroxylase (CYP27B1, 12q13.1), which produces the active hormonal form of 1,25-(OH)2 D. Mutations of CYP2R1 have been associated with vitamin D-dependent rickets type 1B (VDDR1B), a very rare condition that has only been reported to affect 4 families to date. We describe 7 patients from 2 unrelated families who presented with homozygous loss-of-function mutations of CYP2R1. Heterozygous mutations were present in their normal parents. We identified a new c.124_138delinsCGG (p.Gly42_Leu46delinsArg) variation and the previously published c.296T>C (p.Leu99Pro) mutation. Functional in vitro studies confirmed loss-of-function enzymatic activity in both cases. We discuss the difficulties in establishing the correct diagnosis and the specific biochemical pattern, namely, very low 25-OH-D suggestive of classical vitamin D deficiency, in the face of normal/high concentrations of 1,25-(OH)2 D. Siblings exhibited the three stages of rickets based on biochemical and radiographic findings. Interestingly, adult patients were able to maintain normal mineral metabolism without vitamin D supplementation. One index case presented with a partial improvement with 1alfa-hydroxyvitamin D3 or alfacalcidol (1α-OH-D3 ) treatment, and we observed a dramatic increase in the 1,25-(OH)2 D serum concentration, which indicated the role of accessory 25-hydroxylase enzymes. Lastly, in patients who received calcifediol (25-OH-D3 ), we documented normal 24-hydroxylase activity (CYP24A1). For the first time, and according to the concept of personalized medicine, we demonstrate dramatic improvements in patients who were given 25-OH-D therapy (clinical symptoms, biochemical data, and bone densitometry). In conclusion, the current study further expands the CYP2R1 mutation spectrum. We note that VDDR1B could be easily mistaken for classical vitamin D deficiency.
© 2017 American Society for Bone and Mineral Research. © 2017 American Society for Bone and Mineral Research.

Entities:  

Keywords:  25-HYDROXYLASE; GENETICS; PERSONALIZED MEDICINE; RICKETS; VITAMIN D

Mesh:

Substances:

Year:  2017        PMID: 28548312     DOI: 10.1002/jbmr.3181

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  22 in total

Review 1.  New developments in our understanding of vitamin metabolism, action and treatment.

Authors:  Sylvia Christakos; Shanshan Li; Jessica De La Cruz; Daniel D Bikle
Journal:  Metabolism       Date:  2019-06-19       Impact factor: 8.694

Review 2.  Genetics of Refractory Rickets: Identification of Novel PHEX Mutations in Indian Patients and a Literature Update.

Authors:  Binata Marik; Arvind Bagga; Aditi Sinha; Pankaj Hari; Arundhati Sharma
Journal:  J Pediatr Genet       Date:  2018-01-28

3.  Fasting-Induced Transcription Factors Repress Vitamin D Bioactivation, a Mechanism for Vitamin D Deficiency in Diabetes.

Authors:  Sanna-Mari Aatsinki; Mahmoud-Sobhy Elkhwanky; Outi Kummu; Mikko Karpale; Marcin Buler; Pirkko Viitala; Valtteri Rinne; Maija Mutikainen; Pasi Tavi; Andras Franko; Rudolf J Wiesner; Kari T Chambers; Brian N Finck; Jukka Hakkola
Journal:  Diabetes       Date:  2019-03-04       Impact factor: 9.461

Review 4.  Vitamin D Endocrine System and COVID-19: Treatment with Calcifediol.

Authors:  Jose Manuel Quesada-Gomez; José Lopez-Miranda; Marta Entrenas-Castillo; Antonio Casado-Díaz; Xavier Nogues Y Solans; José Luis Mansur; Roger Bouillon
Journal:  Nutrients       Date:  2022-06-29       Impact factor: 6.706

5.  Differential Frequency of CYP2R1 Variants Across Populations Reveals Pathway Selection for Vitamin D Homeostasis.

Authors:  Alex Casella; Caela Long; Jingman Zhou; Meizan Lai; Lauren O'Lear; Ilana Caplan; Michael A Levine; Jeffrey D Roizen
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

Review 6.  Is calcifediol better than cholecalciferol for vitamin D supplementation?

Authors:  J M Quesada-Gomez; R Bouillon
Journal:  Osteoporos Int       Date:  2018-04-30       Impact factor: 4.507

7.  Molecular Control of Phosphorus Homeostasis and Precision Treatment of Hypophosphatemic Disorders.

Authors:  Thomas J Weber; L Darryl Quarles
Journal:  Curr Mol Biol Rep       Date:  2019-02-09

Review 8.  Vitamin D Metabolism Revised: Fall of Dogmas.

Authors:  Roger Bouillon; Dan Bikle
Journal:  J Bone Miner Res       Date:  2019-10-29       Impact factor: 6.741

Review 9.  Rickets in a Thoroughbred-cross foal: case report and review of the literature.

Authors:  Javier Asin; Brian G Murphy; Monika A Samol; Jose Polanco; Janet D Moore; Francisco A Uzal
Journal:  J Vet Diagn Invest       Date:  2021-06-23       Impact factor: 1.569

10.  Calcifediol or vitamin D to optimize vitamin D status: Reply to letter of M Sosas.

Authors:  R Bouillon; J M Quesada-Gomez
Journal:  Osteoporos Int       Date:  2019-10-14       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.